Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04800809 · ClinicalTrials.gov registry record
The Afolabi Stroke Registry for Children and Young Adults With SCD in Northern Nigeria
A clinical trial of Stroke and Sickle Cell Disease, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 350
- Enrollment target
- 3
- Study locations
NCT04800809 is a study of Stroke and Sickle Cell Disease that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 350 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (97% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT04800809, a study of Stroke and Sickle Cell Disease, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 350 participants
- Enrollment target
- 3
- Study locations
Study Summary
Sickle Cell Anemia (SCA) occurs in 300,000 newborns per year in the world, with 150,000 affected births in Nigeria, alone. With improvement in survival for children with SCA in both high- and low-resource countries, neurological morbidity is an emerging significant public health challenge, particularly in countries with a high rate of sickle cell disease (SCD). Both silent cerebral infarcts (SCI) and overt strokes result in significant neurological morbidity and premature death. Five NIH-funded randomized controlled trials (RCT) demonstrated that regular blood transfusion or hydroxyurea therapy are efficacious treatments for primary and secondary stroke prevention in children with SCA. Despite the observation that at least 99% of children with SCA in high-resource settings reach adulthood, and approximately 60% of adults will experience one or more strokes (\~50% with SCI and \~10% with overt strokes) and the high disease-burden in Nigeria, the prevalence and incidence rates of new and recurrent stroke (overt and silent strokes)have not been collected systematically in children and young adults (16-25 years old) with SCA. In the last decade, there has been growing use of stroke registries in economically advanced nations, particularly for epidemiological purposes of trend analysis, clinical effectiveness, compliance to guidelines, assessment of implementation, adoption of novel techniques, and quality improvement process. For the first time in clinical centers in Nigeria, the Investigators will conduct an observational epidemiological study to document the prevalence and track the incidence of new and recurrent strokes in children and young adults with SCD. The Investigators will create a stroke registry referred to as the Afolabi Stroke Registry for Children and Young Adults with Sickle Cell Disease in Nigeria. The overall purpose of the stroke registry is to document the natural history of SCD in a low-resource setting and to improve the quality of the care of chi
Conditions Studied
Interventions
- OTHER This study does not entail offering any intervention; all data collected will be based on standard of care.
Study Locations (3)
Other
- Jamil Galadanci - Kano
- Aminu Kano Teaching Hospital - Kano
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2020-04-01 |
| Est. Completion | 2023-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04800809
The ClinicalTrials.gov registry entry for NCT04800809 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (97% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which This study does not entail offering any intervention; all data collected will be based on standard of care. is the first listed.
NCT04800809 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Other, Tennessee.
Frequently Asked Questions
What is clinical trial NCT04800809 about?
NCT04800809 is a clinical study titled "The Afolabi Stroke Registry for Children and Young Adults With SCD in Northern Nigeria". Sickle Cell Anemia (SCA) occurs in 300,000 newborns per year in the world, with 150,000 affected births in Nigeria, alone. With improvement in survival for children with SCA in both high- and low-resource countries, neurological morbidity is an emerging significant public health challenge, particula...
What is the current status of trial NCT04800809?
This trial is currently completed. The enrollment target is 350 participants. The study started on 2020-04-01. Estimated completion is 2023-12-31.
What conditions does trial NCT04800809 study?
This clinical trial studies the following conditions: Stroke, Sickle Cell Disease, Sickle Cell Anemia, Neurologic Manifestations, Sickle Cell Anemia in Children.
What interventions are being tested in trial NCT04800809?
The interventions under investigation include: This study does not entail offering any intervention; all data collected will be based on standard of care. (OTHER).
Who is sponsoring clinical trial NCT04800809?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04800809 being conducted?
This trial has 3 study locations across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The SLEEPR Study: SLEep Effects on Post-stroke Rehabilitation
RECRUITING
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Genetic and Environmental Risk Factors for Hemorrhagic Stroke
RECRUITING
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.